MedTrace Logo

Primary Care-Based Interventions to Reduce Alcohol Use Among HIV Patients

NCT01671501 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 614

Last updated 2018-10-10

No results posted yet for this study

Summary

This randomized clinical trial uses a health plan's electronic medical record (EMR) alcohol screen; and examines innovative behavioral interventions, and their cost effectiveness, for hazardous drinking within a large HIV primary care clinic. We will compare Motivational Interviewing (MI) and Email Feedback (EF) to usual care; and evaluate the effect of the interventions on unhealthy drinking, comorbid drug use, enrollment in substance use treatment programs, and HIV outcomes including antiretroviral therapy adherence, HIV RNA control, and unsafe sex. Given the well-known adverse effects of unhealthy drinking on HIV care and outcomes, the proposed study has the potential to make a significant impact in the care of HIV patients.

Conditions

  • HIV
  • Acquired Immunodeficiency Syndrome
  • Alcoholism
  • Alcoholic Intoxication
  • Substance-Related Disorders

Interventions

BEHAVIORAL

Motivational Interviewing

BEHAVIORAL

Email Feedback

OTHER

Usual Care

Sponsors & Collaborators

Principal Investigators

  • Derek Satre, PhD · Associate Professor, University of California, San Francisco and Adjunct Investigator, Division of Research, Kaiser Permanente, Northern California

  • Michael J Silverberg, PhD · Research Scientist II, Division of Research, Kaiser Permanente, Northern California

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2016-08-31
Completion
2017-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01671501 on ClinicalTrials.gov